UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $9

Benzinga · 3d ago
UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and lowers the price target from $22 to $9.